Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 362 articles:
HTML format



Single Articles


    September 2020
  1. NAYYAR A, Strassle PD, Iles K, Jameison D, et al
    Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women.
    Ann Surg Oncol. 2020 Sep 11. pii: 10.1245/s10434-020-08945.
    PubMed     Abstract available


  2. ALBERTY-OLLER JJ, Weltz S, Santos A, Pisapati K, et al
    Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
    Ann Surg Oncol. 2020 Sep 11. pii: 10.1245/s10434-020-09123.
    PubMed     Abstract available


  3. BHUROSY T, Niu Z, Heckman CJ
    Breastfeeding is Possible: A Systematic Review on the Feasibility and Challenges of Breastfeeding Among Breast Cancer Survivors of Reproductive Age.
    Ann Surg Oncol. 2020 Sep 11. pii: 10.1245/s10434-020-09094.
    PubMed     Abstract available


  4. BAUMRUCKER CC, Spring SR, Cohen BL, Millen JC, et al
    The Effect of Hospital Volume on Outcomes of Patients with Occult Breast Cancer.
    Ann Surg Oncol. 2020 Sep 10. pii: 10.1245/s10434-020-09103.
    PubMed     Abstract available


  5. STAFFORD A, Williams A, Edmiston K, Cocilovo C, et al
    Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis.
    Ann Surg Oncol. 2020 Sep 9. pii: 10.1245/s10434-020-08905.
    PubMed     Abstract available


  6. COOK JA, Hassanein AH
    ASO Author Reflections: Immediate Lymphatic Reconstruction: A Proactive Approach to Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2020 Sep 4. pii: 10.1245/s10434-020-09110.
    PubMed    


  7. CHEN JJ, von Eyben R, Gutkin PM, Hawley E, et al
    Development of a Classification Tree to Predict Implant-Based Reconstruction Failure with or without Postmastectomy Radiation Therapy for Breast Cancer.
    Ann Surg Oncol. 2020 Sep 1. pii: 10.1245/s10434-020-09068.
    PubMed     Abstract available


    August 2020
  8. KANTOR O, Wakeman M, Weiss A, Wong S, et al
    Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2020 Aug 31. pii: 10.1245/s10434-020-09073.
    PubMed     Abstract available


  9. ASAAD M, Meaike J, Yonkus J, Hoskin T, et al
    Breast Reconstruction in the Setting of Stage 4 Breast Cancer: Is It Worthwhile?
    Ann Surg Oncol. 2020 Aug 25. pii: 10.1245/s10434-020-08879.
    PubMed     Abstract available


  10. BOTTY VAN DEN BRUELE A, Lavery J, Plitas G, Pilewskie ML, et al
    Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Aug 19. pii: 10.1245/s10434-020-08863.
    PubMed     Abstract available


  11. PANDA N, Solsky I, Hawrusik B, Liu G, et al
    Smartphone Global Positioning System (GPS) Data Enhances Recovery Assessment After Breast Cancer Surgery.
    Ann Surg Oncol. 2020 Aug 18. pii: 10.1245/s10434-020-09004.
    PubMed     Abstract available


  12. ROSENKRANZ KM, Boughey JC
    ASO Author Reflections: Multiple Ipsilateral Breast Cancer: Where Have We Been, Where are We Going.
    Ann Surg Oncol. 2020 Aug 17. pii: 10.1245/s10434-020-08983.
    PubMed    


  13. PILTIN MA, Hoskin TL, Day CN, Davis J Jr, et al
    Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer.
    Ann Surg Oncol. 2020 Aug 10. pii: 10.1245/s10434-020-08900.
    PubMed     Abstract available


  14. HUANG TW, Su CM, Tam KW
    Correction to: Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.
    Ann Surg Oncol. 2020 Aug 10. pii: 10.1245/s10434-020-08987.
    PubMed     Abstract available


  15. CROWN A, Muhsen S, Zabor EC, Sevilimedu V, et al
    Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
    Ann Surg Oncol. 2020 Aug 7. pii: 10.1245/s10434-020-08883.
    PubMed     Abstract available


  16. MOTT N, Dossett LA
    ASO Author Reflections: Can Medical Maximizing-Minimizing Preferences Inform De-implementation Efforts for Low-Value Breast Cancer Services in Older Women?
    Ann Surg Oncol. 2020 Aug 5. pii: 10.1245/s10434-020-09009.
    PubMed    


    July 2020
  17. ALMAHARIQ MF, Chen PY, Dekhne N, Dilworth JT, et al
    ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
    Ann Surg Oncol. 2020 Jul 31. pii: 10.1245/s10434-020-08966.
    PubMed    


  18. POSTLEWAIT LM, Lucci A
    ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer-Need for Clinical Trials to Reassess Standard of Care.
    Ann Surg Oncol. 2020 Jul 31. pii: 10.1245/s10434-020-08952.
    PubMed    


  19. PILTIN MA, Boughey JC
    ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
    Ann Surg Oncol. 2020 Jul 31. pii: 10.1245/s10434-020-08954.
    PubMed    


  20. BASKIN AS, Wang T, Mott NM, Hawley ST, et al
    Gaps in Online Breast Cancer Treatment Information for Older Women.
    Ann Surg Oncol. 2020 Jul 30. pii: 10.1245/s10434-020-08961.
    PubMed     Abstract available


  21. DAVIS J JR, Hoskin TL, Day CN, Wickre M, et al
    Performance and Clinical Utility of Models Predicting Eradication of Nodal Disease in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy by Tumor Biology.
    Ann Surg Oncol. 2020 Jul 29. pii: 10.1245/s10434-020-08885.
    PubMed     Abstract available


  22. DAUPHINE C
    ASO Author Reflections: Time for a Paradigm Shift in "Hormone Receptor Positive" Invasive Breast Cancer?
    Ann Surg Oncol. 2020 Jul 28. pii: 10.1245/s10434-020-08950.
    PubMed    


  23. BOTTY VAN DEN BRUELE A, Plitas G, Pilewskie M
    ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.
    Ann Surg Oncol. 2020 Jul 28. pii: 10.1245/s10434-020-08939.
    PubMed    


  24. GARCIA-NOVOA A, Acea-Nebril B, Diaz Carballada C, Bouzon Alejandro A, et al
    Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study.
    Ann Surg Oncol. 2020 Jul 28. pii: 10.1245/s10434-020-08925.
    PubMed     Abstract available


  25. MURPHY BL, Yi M, Arun BK, Gutierrez Barrera AM, et al
    Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
    Ann Surg Oncol. 2020 Jul 27. pii: 10.1245/s10434-020-08889.
    PubMed     Abstract available


  26. PLICHTA JK
    ASO Author Reflections: What is the Most Appropriate Surgical Management for Men with Breast Cancer?
    Ann Surg Oncol. 2020 Jul 27. pii: 10.1245/s10434-020-08951.
    PubMed    


  27. AMIN AL, Wagner JL
    ASO Author Reflections: ADH Upgrade Rate is Not Elevated by Presence of Ipsilateral Concurrent Breast Cancer.
    Ann Surg Oncol. 2020 Jul 27. pii: 10.1245/s10434-020-08947.
    PubMed    


  28. DAVID NATHANSON S, Leonard-Murali S, Burmeister C, Susick L, et al
    Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes.
    Ann Surg Oncol. 2020 Jul 27. pii: 10.1245/s10434-020-08904.
    PubMed     Abstract available


  29. MOTT N, Wang T, Miller J, Berlin NL, et al
    Medical Maximizing-Minimizing Preferences in Relation to Low-Value Services for Older Women with Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
    Ann Surg Oncol. 2020 Jul 27. pii: 10.1245/s10434-020-08924.
    PubMed     Abstract available


  30. ALMAHARIQ MF, Levitin R, Quinn TJ, Chen PY, et al
    Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Jul 25. pii: 10.1245/s10434-020-08928.
    PubMed     Abstract available


  31. AHMADIYEH N
    ASO Author Reflections: Breast Cancer Screening in the Safety-Net: Trying to Close the Gap When the Fault Lines Go Deep.
    Ann Surg Oncol. 2020 Jul 25. pii: 10.1245/s10434-020-08935.
    PubMed    


  32. POSTLEWAIT LM, Teshome M, DeSnyder SM, Lim B, et al
    Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
    Ann Surg Oncol. 2020 Jul 24. pii: 10.1245/s10434-020-08891.
    PubMed     Abstract available


  33. AMIN AL, Fan F, Winblad OD, Larson KE, et al
    Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?
    Ann Surg Oncol. 2020 Jul 23. pii: 10.1245/s10434-020-08896.
    PubMed     Abstract available


  34. HUANG TW, Su CM, Tam KW
    Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.
    Ann Surg Oncol. 2020 Jul 23. pii: 10.1245/s10434-020-08923.
    PubMed     Abstract available


  35. PLICHTA JK, Ren Y, Marks CE, Thomas SM, et al
    Surgery for Men with Breast Cancer: Do the Same Data Still Apply?
    Ann Surg Oncol. 2020 Jul 23. pii: 10.1245/s10434-020-08901.
    PubMed     Abstract available


  36. KRELL RW, Spanheimer PM
    Primary Site Surgery and Survival Impact in Metastatic HER2-Amplified Breast Cancer: Responsible use of Cohort Data.
    Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08868.
    PubMed    


  37. ROSENKRANZ KM, Ballman K, McCall L, McCarthy C, et al
    Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study.
    Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08893.
    PubMed     Abstract available


  38. NATHANSON SD
    ASO Author Reflections: Is Breast Cancer Dissemination Lymphatic, Hematogenous, or Both; and Does It Matter?
    Ann Surg Oncol. 2020 Jul 21. pii: 10.1245/s10434-020-08932.
    PubMed    


  39. LAWS A, Mulvey TM, Jalbert N, Dalton S, et al
    Baseline Screening MRI Uptake and Findings in Women with >/= 20% Lifetime Risk of Breast Cancer.
    Ann Surg Oncol. 2020 Jul 18. pii: 10.1245/s10434-020-08853.
    PubMed     Abstract available


  40. SUN J, Loftus LS, Lee MC
    ASO Author Reflections: The De-Escalation of Sentinel Node Biopsy for Breast Cancer.
    Ann Surg Oncol. 2020 Jul 14. pii: 10.1245/s10434-020-08854.
    PubMed    


  41. ZHU S, Chen X, Shen K
    ASO Author Reflections: Core Needle Biopsy and Hormonal Receptor Retesting in Breast Cancer: Controversy and Management.
    Ann Surg Oncol. 2020 Jul 13. pii: 10.1245/s10434-019-07961.
    PubMed    


  42. WRUBEL E, Natwick R, Wright GP
    Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database.
    Ann Surg Oncol. 2020 Jul 13. pii: 10.1245/s10434-020-08829.
    PubMed     Abstract available


  43. WANG T, Baskin A, Miller J, Metz A, et al
    Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.
    Ann Surg Oncol. 2020 Jul 10. pii: 10.1245/s10434-020-08823.
    PubMed     Abstract available


  44. ZHANG M, Wu K, Wang M, Chen H, et al
    ASO Author Reflections: Breast-Conserving Surgery Could be Performed Safely in Well-Selected T1-T2 Centrally Located Breast Cancer.
    Ann Surg Oncol. 2020 Jul 9. pii: 10.1245/s10434-020-08839.
    PubMed    


  45. ZHANG M, Wu K, Zhang P, Wang M, et al
    Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer.
    Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08793.
    PubMed     Abstract available


  46. OKUNO J, Miyake T, Shimazu K, Noguchi S, et al
    ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
    Ann Surg Oncol. 2020 Jul 6. pii: 10.1245/s10434-020-08797.
    PubMed    


  47. BAILEY CM, Selber J, Liu J, Lee CN, et al
    Current Practice and Perceptions Regarding Cost Communication in Breast Cancer Reconstruction: Survey Results of the American Society of Plastic Surgeons.
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08750.
    PubMed     Abstract available


  48. SUN J, Mathias BJ, Sun W, Fulp WJ, et al
    Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08759.
    PubMed     Abstract available


    June 2020
  49. WEISS A, King TA, Mittendorf EA
    The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.
    Ann Surg Oncol. 2020 Jun 26. pii: 10.1245/s10434-020-08530.
    PubMed     Abstract available


  50. OKUNO J, Miyake T, Sota Y, Tanei T, et al
    Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2020 Jun 24. pii: 10.1245/s10434-020-08735.
    PubMed     Abstract available


  51. CHANG YT, Shih SL, Loh EW, Tam KW, et al
    Effects of Fibrin Sealant on Seroma Reduction for Patients with Breast Cancer Undergoing Axillary Dissection: Meta-Analysis of Randomized Controlled Trials.
    Ann Surg Oncol. 2020 Jun 20. pii: 10.1245/s10434-020-08747.
    PubMed     Abstract available


  52. COOPEY SB
    ASO Author Reflections: Breast Cancer Detection of Baseline Screening MRI in High-Risk Women Who Are Not in the Highest Risk Groups.
    Ann Surg Oncol. 2020 Jun 12. pii: 10.1245/s10434-020-08722.
    PubMed    


  53. TAMBURELLI F, Ponzone R
    The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.
    Ann Surg Oncol. 2020 Jun 10. pii: 10.1245/s10434-020-08704.
    PubMed     Abstract available


  54. PONZONE R
    ASO Author Reflections: The Difficult Assessment of the Hard-Won Progress of Breast Cancer Care.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08719.
    PubMed    


  55. ALVARADO MD, Mittendorf EA, Teshome M, Thompson AM, et al
    Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08688.
    PubMed     Abstract available


  56. MONTAGNA G, Morrow M
    ASO Author Reflections: Axillary Staging in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy-Beyond Clinical Trials.
    Ann Surg Oncol. 2020 Jun 4. pii: 10.1245/s10434-020-08693.
    PubMed    


  57. GUTNIK L, Allen CM, Presson AP, Matsen CB, et al
    Breast Cancer Surgery Decision Role Perceptions and Choice of Surgery.
    Ann Surg Oncol. 2020 Jun 3. pii: 10.1245/s10434-020-08485.
    PubMed     Abstract available


  58. JAMES TA, Fan B
    ASO Author Reflections: Limiting Axillary Surgery for Microinvasive Breast Cancer.
    Ann Surg Oncol. 2020 Jun 2. pii: 10.1245/s10434-020-08694.
    PubMed    


    May 2020
  59. STEIN MJ, Karir A, Arnaout A, Roberts A, et al
    Quality-of-Life and Surgical Outcomes for Breast Cancer Patients Treated with Therapeutic Reduction Mammoplasty Versus Mastectomy with Immediate Reconstruction.
    Ann Surg Oncol. 2020 May 30. pii: 10.1245/s10434-020-08574.
    PubMed     Abstract available


  60. WILLIAMS AD, McGreevy CM, Tchou JC, De La Cruz LM, et al
    Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
    Ann Surg Oncol. 2020 May 29. pii: 10.1245/s10434-020-08473.
    PubMed     Abstract available


  61. STEIN MJ, Arnaout A, Zhang J
    ASO Author Reflections: The Evolving Field of Oncoplastic Breast Conservation for the Management of Breast Cancer.
    Ann Surg Oncol. 2020 May 26. pii: 10.1245/s10434-020-08594.
    PubMed    


  62. MAMTANI A, Morrow M
    ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
    Ann Surg Oncol. 2020 May 21. pii: 10.1245/s10434-020-08634.
    PubMed    


  63. MAGNONI F, Intra M
    ASO Author Reflections: Future View: A Recent Scientific Contribution Towards a Staging Revision of Contralateral Axillary Lymph Node Metastases from Breast Cancer.
    Ann Surg Oncol. 2020 May 19. pii: 10.1245/s10434-020-08612.
    PubMed    


  64. FAN B, Pardo JA, Serres S, Alapati AC, et al
    Role of Sentinel Lymph Node Biopsy in Microinvasive Breast Cancer.
    Ann Surg Oncol. 2020 May 19. pii: 10.1245/s10434-020-08606.
    PubMed     Abstract available


  65. GREENUP RA, Prakash I, Sorenson C
    "Choosing Wisely" in Breast Cancer Surgery: Drivers of Low Value Care.
    Ann Surg Oncol. 2020 May 15. pii: 10.1245/s10434-020-08584.
    PubMed    


  66. SCHWARZ J, Schmidt H
    Correction to: Technology for Intraoperative Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2020 May 13. pii: 10.1245/s10434-020-08573.
    PubMed     Abstract available


    April 2020
  67. SCHWARZ J, Schmidt H
    Technology for Intraoperative Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2020 Apr 29. pii: 10.1245/s10434-020-08483.
    PubMed     Abstract available


  68. TRAN HT, Jackson RS
    ASO Author Reflections: Preoperative Nomogram Identifies Patients for Selective Omission of SLNB in Breast Cancer-to Promote Implementation of the Choosing Wisely Campaign Recommendations.
    Ann Surg Oncol. 2020 Apr 29. pii: 10.1245/s10434-020-08288.
    PubMed    


  69. WILLIAMS AD, De La Cruz LM
    ASO Author Reflections: No Profiling in Male Breast Cancer: Where We are and Where We Should Be.
    Ann Surg Oncol. 2020 Apr 26. pii: 10.1245/s10434-020-08504.
    PubMed    


  70. VALENTE SA, Shah C
    The Landmark Series: Adjuvant Radiation Therapy for Breast Cancer.
    Ann Surg Oncol. 2020 Apr 20. pii: 10.1245/s10434-020-08450.
    PubMed     Abstract available


  71. YOON JH, Koo JS, Lee HS, Kim EK, et al
    Factors Predicting Breast Cancer Development in Women During Surveillance After Surgery for Atypical Ductal Hyperplasia of the Breast: Analysis of Clinical, Radiologic, and Histopathologic Features.
    Ann Surg Oncol. 2020 Apr 20. pii: 10.1245/s10434-020-08476.
    PubMed     Abstract available


  72. MOLDOVEANU D, Pravongviengkham V, Best G, Martinez C, et al
    Dynamic Neutrophil-to-Lymphocyte Ratio: A Novel Prognosis Measure for Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2020 Apr 20. pii: 10.1245/s10434-020-08302.
    PubMed     Abstract available


  73. KOVAR A, Bronsert M, Jaiswal K, Murphy C, et al
    The Waiting Game: How Long Are Breast Cancer Patients Waiting for Definitive Diagnosis?
    Ann Surg Oncol. 2020 Apr 20. pii: 10.1245/s10434-020-08484.
    PubMed     Abstract available


  74. RETROUVEY H, Zhong T, Gagliardi AR, Baxter NN, et al
    How Ineffective Interprofessional Collaboration Affects Delivery of Breast Reconstruction to Breast Cancer Patients: A Qualitative Study.
    Ann Surg Oncol. 2020 Apr 15. pii: 10.1245/s10434-020-08463.
    PubMed     Abstract available


  75. VAN STEENHOVEN JEC, van Dalen T
    ASO Author Reflections: Effect Sizes of Whole Breast Radiotherapy and Systemic Therapies on Regional Recurrence Incidence in Breast Cancer Patients.
    Ann Surg Oncol. 2020 Apr 4. pii: 10.1245/s10434-020-08434.
    PubMed    


  76. MCGUIRE KP, Mamounas EP
    Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline.
    Ann Surg Oncol. 2020 Apr 3. pii: 10.1245/s10434-020-08396.
    PubMed    


    March 2020
  77. ZHELEVA V, Lai LL
    ASO Author Reflections: A Call to Modify Factors Predictive of Noncompliance with Quality Measures in Breast Cancer Treatment.
    Ann Surg Oncol. 2020 Mar 31. pii: 10.1245/s10434-020-08405.
    PubMed    


  78. OBENG-GYASI S, Haggstrom D
    ASO Author Reflections: Tackling Breast Cancer Disparities in Rural America: An Old Challenge in a New Decade.
    Ann Surg Oncol. 2020 Mar 28. pii: 10.1245/s10434-020-08383.
    PubMed    


  79. JOGERST K, Thomas O, Kosiorek HE, Gray R, et al
    Same-Day Discharge After Mastectomy: Breast Cancer Surgery in the Era of ERAS((R)).
    Ann Surg Oncol. 2020 Mar 27. pii: 10.1245/s10434-020-08386.
    PubMed     Abstract available


  80. LOUIE RJ, Gaber CE, Strassle PD, Gallagher KK, et al
    Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment.
    Ann Surg Oncol. 2020 Mar 25. pii: 10.1245/s10434-020-08388.
    PubMed     Abstract available


  81. PAK LM, Banaag A, Koehlmoos TP, Nguyen LL, et al
    Non-clinical Drivers of Variation in Preoperative MRI Utilization for Breast Cancer.
    Ann Surg Oncol. 2020 Mar 25. pii: 10.1245/s10434-020-08380.
    PubMed     Abstract available


  82. OBENG-GYASI S, Timsina L, Bhattacharyya O, Fisher CS, et al
    Breast Cancer Presentation, Surgical Management and Mortality Across the Rural-Urban Continuum in the National Cancer Database.
    Ann Surg Oncol. 2020 Mar 23. pii: 10.1245/s10434-020-08376.
    PubMed     Abstract available


  83. NODA M, Masuda T, Ito S, Tobo T, et al
    Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients.
    Ann Surg Oncol. 2020 Mar 21. pii: 10.1245/s10434-020-08375.
    PubMed     Abstract available


  84. VAN STEENHOVEN JEC, Kuijer A, van Maaren MC, Roos M, et al
    Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients.
    Ann Surg Oncol. 2020 Mar 20. pii: 10.1245/s10434-020-08356.
    PubMed     Abstract available


  85. ZHELEVA V, Nelson RA, Dumitra S, Vora NL, et al
    Time to Adjuvant Radiotherapy in Breast Cancer Affects Survival: Implications for the American College of Surgeons Commission on Cancer Quality Metrics.
    Ann Surg Oncol. 2020 Mar 17. pii: 10.1245/s10434-020-08326.
    PubMed     Abstract available


  86. SMITH BL, Kelly BN, Gadd MA
    ASO Author Reflections: Image-Guided Margin Assessment for Breast Cancer.
    Ann Surg Oncol. 2020 Mar 16. pii: 10.1245/s10434-020-08332.
    PubMed    


  87. MUDGWAY R, Lum SS
    ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08347.
    PubMed    


  88. SMITH BL, Lanahan CR, Specht MC, Kelly BN, et al
    Correction to: Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08349.
    PubMed     Abstract available


  89. COHEN BL, Macedo FI
    ASO Author Reflections: SLNB with RT May Be Sufficient in Occult Breast Cancer after NAC.
    Ann Surg Oncol. 2020 Mar 10. pii: 10.1245/s10434-020-08345.
    PubMed    


  90. MUDGWAY R, Chavez de Paz Villanueva C, Lin AC, Senthil M, et al
    The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy.
    Ann Surg Oncol. 2020 Mar 10. pii: 10.1245/s10434-020-08310.
    PubMed     Abstract available


  91. SMITH ME, Vitous CA, Hughes TM, Shubeck SP, et al
    Barriers and Facilitators to De-Implementation of the Choosing Wisely((R)) Guidelines for Low-Value Breast Cancer Surgery.
    Ann Surg Oncol. 2020 Mar 2. pii: 10.1245/s10434-020-08285.
    PubMed     Abstract available


  92. YAMAGISHI Y, Yamasaki T, Ishida J, Moriya T, et al
    Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast Cancer.
    Ann Surg Oncol. 2020 Mar 2. pii: 10.1245/s10434-020-08269.
    PubMed     Abstract available


    February 2020
  93. LAWS A, Xu Y, Kong S, Brisson AM, et al
    Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings.
    Ann Surg Oncol. 2020 Feb 25. pii: 10.1245/s10434-020-08259.
    PubMed     Abstract available


  94. SI Y, Yuan P
    ASO Author Reflections: Effect of Primary Surgery on Quality of Life in De Novo Stage IV Breast Cancer Patients.
    Ann Surg Oncol. 2020 Feb 7. pii: 10.1245/s10434-019-08130.
    PubMed    


  95. TRAN HT, Pack D, Mylander C, Martino L, et al
    Ultrasound-Based Nomogram Identifies Breast Cancer Patients Unlikely to Harbor Axillary Metastasis: Towards Selective Omission of Sentinel Lymph Node Biopsy.
    Ann Surg Oncol. 2020 Feb 5. pii: 10.1245/s10434-019-08164.
    PubMed     Abstract available


  96. CASTELO M, Hu SY, Dossa F, Acuna SA, et al
    Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
    Ann Surg Oncol. 2020 Feb 4. pii: 10.1245/s10434-020-08225.
    PubMed     Abstract available


  97. LAI HW, Chen ST, Tai CM, Lin SL, et al
    Robotic- Versus Endoscopic-Assisted Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction in the Management of Breast Cancer: A Case-Control Comparison Study with Analysis of Clinical Outcomes, Learning Curve, Patient-Reported Aest
    Ann Surg Oncol. 2020 Feb 3. pii: 10.1245/s10434-020-08223.
    PubMed     Abstract available


    January 2020
  98. COHEN BL, Collier AL, Kelly KN, Goel N, et al
    Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Jan 27. pii: 10.1245/s10434-020-08227.
    PubMed     Abstract available


  99. SI Y, Yuan P, Hu N, Wang X, et al
    Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
    Ann Surg Oncol. 2020 Jan 22. pii: 10.1245/s10434-019-08092.
    PubMed     Abstract available


  100. NELSON RA, Bostanci Z, Jones V, Mortimer J, et al
    Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in California.
    Ann Surg Oncol. 2020 Jan 21. pii: 10.1245/s10434-019-08116.
    PubMed     Abstract available


  101. DIAO K, Smith BD
    ASO Author Reflections: Impact of Surgical Subspecialization in Breast Cancer-The Case for Fellowship Training.
    Ann Surg Oncol. 2020 Jan 21. pii: 10.1245/s10434-020-08214.
    PubMed    


  102. GROHEUX D, Hindie E
    (18)FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher : Commentary on "Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer" by Marissa K. Srour et al.
    Ann Surg Oncol. 2020 Jan 13. pii: 10.1245/s10434-019-08188.
    PubMed    


  103. QIU PF, Zhao RR, Wang W, Sun X, et al
    Correction to: Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management.
    Ann Surg Oncol. 2020 Jan 9. pii: 10.1245/s10434-020-08196.
    PubMed     Abstract available


  104. SMITH BD, Lei X, Diao K, Xu Y, et al
    Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.
    Ann Surg Oncol. 2020 Jan 8. pii: 10.1245/s10434-019-08165.
    PubMed     Abstract available


  105. KANTOR O, Niu J, Zhao H, Giordano SH, et al
    Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging.
    Ann Surg Oncol. 2020 Jan 8. pii: 10.1245/s10434-019-08169.
    PubMed     Abstract available


  106. SROUR MK, Amersi F
    Response to Letter to the Editor: "18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher".
    Ann Surg Oncol. 2020 Jan 6. pii: 10.1245/s10434-019-08194.
    PubMed    


  107. SOLIMAN H, Wagner S, Flake DD 2nd, Robson M, et al
    Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2020 Jan 6. pii: 10.1245/s10434-019-08039.
    PubMed     Abstract available


  108. STANKOWSKI-DRENGLER TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, et al
    Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01).
    Ann Surg Oncol. 2020 Jan 3. pii: 10.1245/s10434-019-07846.
    PubMed     Abstract available


  109. SMITH BL, Lanahan CR, Specht MC, Kelly BN, et al
    Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Ann Surg Oncol. 2020 Jan 2. pii: 10.1245/s10434-019-08158.
    PubMed     Abstract available


    December 2019
  110. WIMMER K, Bolliger M, Bago-Horvath Z, Steger G, et al
    Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival.
    Ann Surg Oncol. 2019 Dec 23. pii: 10.1245/s10434-019-08089.
    PubMed     Abstract available


  111. VALERO MG, King TA, Pilewskie ML
    ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS-More Work Is Needed.
    Ann Surg Oncol. 2019 Dec 20. pii: 10.1245/s10434-019-07936.
    PubMed    


  112. FISHER CS, Margenthaler JA, Hunt KK, Schwartz T, et al
    The Landmark Series: Axillary Management in Breast Cancer.
    Ann Surg Oncol. 2019 Dec 20. pii: 10.1245/s10434-019-08154.
    PubMed     Abstract available


  113. VALERO MG, Muhsen S, Moo TA, Zabor EC, et al
    Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes.
    Ann Surg Oncol. 2019 Dec 10. pii: 10.1245/s10434-019-07948.
    PubMed     Abstract available


  114. SILVA E, Tan M
    ASO Author Reflections: Why the Surgeon, Who is the Person Most Influential in the Management of Breast Cancer, Must Have a Multidisciplinary Mindset.
    Ann Surg Oncol. 2019 Dec 6. pii: 10.1245/s10434-019-08053.
    PubMed    


  115. DOWNS-CANNER S, Heerdt A
    Reply to "Downs-Canner S, Zabor EC, Wind T, Cobovic A, McCormick B, Morrow M, Heerdt A. Radiation Therapy After Breast-Conserving Surgery for Women 70 Years of Age or Older: How Wisely Do We Choose? In Regard to Downs-Canner et al." by Hannoun-Levi, J
    Ann Surg Oncol. 2019;26.
    PubMed    


  116. HANNOUN-LEVI JM, Hannoun A
    Downs-Canner S, Zabor EC, Wind T, Cobovic A, McCormick B, Morrow M, Heerdt A-Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose? In Regard to Downs-Canner et al.
    Ann Surg Oncol. 2019;26.
    PubMed    


    November 2019
  117. CHRISTIAN N, Gemignani ML
    ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization.
    Ann Surg Oncol. 2019 Nov 14. pii: 10.1245/s10434-019-08082.
    PubMed    


  118. POMPONIO M, Keele L, Hilt E, Burkbauer L, et al
    Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative </= T1b Breast Cancer.
    Ann Surg Oncol. 2019 Nov 4. pii: 10.1245/s10434-019-08028.
    PubMed     Abstract available


  119. CONLEY CC, Kasting ML, Augusto BM, Garcia JD, et al
    Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
    Ann Surg Oncol. 2019 Nov 1. pii: 10.1245/s10434-019-07982.
    PubMed     Abstract available


    October 2019
  120. YI M, Lin H, Bedrosian I, Shen Y, et al
    Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.
    Ann Surg Oncol. 2019 Oct 30. pii: 10.1245/s10434-019-07983.
    PubMed     Abstract available


  121. HUEMAN MT, Shriver CD, Ellsworth RE
    ASO Author Reflections: Mitigating Survival Disparities in African American Women with Breast Cancer within the US Military Healthcare System-The Impact of Equivalent Care.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-08007.
    PubMed    


  122. SINGH P, Kuerer HM
    ASO Author Reflections: Neoadjuvant Radiotherapy Followed by Immediate Breast Reconstruction Represents a Novel Therapeutic Sequence for Breast Cancer.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-07975.
    PubMed    


  123. QIAO E, Yu X, Zhou L, Wang C, et al
    A Prospective Validation Cohort Study of a Prediction Model on Non-sentinel Lymph Node Involvement in Early Breast Cancer.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-07980.
    PubMed     Abstract available


  124. SUN SX, Kuerer HM
    ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials-Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2019 Oct 25. pii: 10.1245/s10434-019-07943.
    PubMed    


  125. VAN STEENHOVEN JEC, van Dalen T
    ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2019 Oct 24. pii: 10.1245/s10434-019-07955.
    PubMed    


  126. YAO K, Belkora J, Lee C, Kuchta K, et al
    An In-Visit Decision Aid for Surgeons to Address Decision Making for Bilateral Mastectomy for Newly Diagnosed Breast Cancer Patients.
    Ann Surg Oncol. 2019 Oct 17. pii: 10.1245/s10434-019-07912.
    PubMed     Abstract available


  127. MORENCY D, Dumitra S, Parvez E, Martel K, et al
    Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07809.
    PubMed     Abstract available


  128. RABER BM, Lin H, Shen Y, Shaitelman SF, et al
    Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07901.
    PubMed     Abstract available


  129. GLAESER A, Sinn HP, Garcia-Etienne C, Riedel F, et al
    Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07915.
    PubMed     Abstract available


  130. MIYASHITA M, Niikura N, Tokuda Y
    ASO Author Reflections: Impact of Radiotherapy for Breast Cancer is Changing in the Modern Era.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07941.
    PubMed    


  131. HEEG E, Civil YA, Hillen MA, Smorenburg CH, et al
    Impact of Second Opinions in Breast Cancer Diagnostics and Treatment: A Retrospective Analysis.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07907.
    PubMed     Abstract available


  132. ACEA-NEBRIL B, Garcia-Novoa A
    ASO Author Reflections: Less is Better in Breast Cancer Surgery.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07940.
    PubMed    


  133. TAYLOR W
    Presidential Address: On Resisting the Narcissism of the Present.
    Ann Surg Oncol. 2019;26:3015-3017.
    PubMed    


  134. HOLMES D, Kuerer HM
    Comprehensive Breast Care for the Future from the American Society of Breast Surgeons.
    Ann Surg Oncol. 2019;26:3013-3014.
    PubMed    


  135. REYES SA, De La Cruz LM, Ru M, Pisapati KV, et al
    Practice Changing Potential of TAILORx: A Retrospective Review of the National Cancer Data Base from 2010 to 2015.
    Ann Surg Oncol. 2019;26:3397-3408.
    PubMed     Abstract available


    September 2019
  136. WARD WH, DeMora L, Handorf E, Sigurdson ER, et al
    Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.
    Ann Surg Oncol. 2019 Sep 27. pii: 10.1245/s10434-019-07844.
    PubMed     Abstract available


  137. WEISS A, Wong S, Golshan M, Freedman RA, et al
    Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach.
    Ann Surg Oncol. 2019 Sep 27. pii: 10.1245/s10434-019-07785.
    PubMed     Abstract available


  138. EUHUS DM
    Why Breast Cancer Risk Models Fail: The Case of Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2019 Sep 27. pii: 10.1245/s10434-019-07875.
    PubMed    


  139. VALERO MG, Zabor EC, Park A, Gilbert E, et al
    The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Ann Surg Oncol. 2019 Sep 26. pii: 10.1245/s10434-019-07814.
    PubMed     Abstract available


  140. MILLER ME, Muhsen S, Zabor EC, Flynn J, et al
    Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2019 Sep 24. pii: 10.1245/s10434-019-07796.
    PubMed     Abstract available


  141. VANDE WALLE K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, et al
    Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.
    Ann Surg Oncol. 2019 Sep 19. pii: 10.1245/s10434-019-07726.
    PubMed     Abstract available


  142. MURPHY BL, Boughey JC
    ASO Author Reflections: Disease Patterns and Treatment of Adolescents and Young Women with Breast Cancer.
    Ann Surg Oncol. 2019 Sep 18. pii: 10.1245/s10434-019-07835.
    PubMed    


  143. GARCIA D, Nasarre P, Bonilla IV, Hilliard E, et al
    Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
    Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07800.
    PubMed     Abstract available


  144. RIDNER S, Vicini F, Dietrich MS, Shah C, et al
    Response to Letter to the Editor Regarding "A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis".
    Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07804.
    PubMed    


  145. VAN BOMMEL A, van Dalen T
    ASO Author Reflections: Breast Contour-Preserving Procedures as a Means to Address the Esthetic Outcome of Breast Cancer Treatment.
    Ann Surg Oncol. 2019 Sep 4. pii: 10.1245/s10434-019-07770.
    PubMed    


  146. ZUCCA-MATTHES G, Lebovic G
    Reflection on Consensus Statement on Oncoplastic Surgery.
    Ann Surg Oncol. 2019;26:3005-3006.
    PubMed    


    August 2019
  147. MAMTANI A, Morrow M
    ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07769.
    PubMed    


  148. OZKURT E, Golshan M
    ASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07759.
    PubMed    


  149. BARRIO AV, Brunelle C, Morrow M, Taghian AG, et al
    Letter to Editor re: Ridner et al.: "A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis".
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07763.
    PubMed    


  150. ANKER AM, Prantl L, Strauss C, Brebant V, et al
    Assessment of DIEP Flap Perfusion with Intraoperative Indocyanine Green Fluorescence Imaging in Vasopressor-Dominated Hemodynamic Support Versus Liberal Fluid Administration: A Randomized Controlled Trial With Breast Cancer Patients.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07758.
    PubMed     Abstract available


  151. MAMTANI A, Zabor EC, Rosenberger LH, Stempel M, et al
    Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?
    Ann Surg Oncol. 2019 Aug 27. pii: 10.1245/s10434-019-07751.
    PubMed     Abstract available


  152. MULLER HD, Posch F, Suppan C, Bargfrieder U, et al
    Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
    Ann Surg Oncol. 2019 Aug 26. pii: 10.1245/s10434-019-07741.
    PubMed     Abstract available


  153. BOUGHEY JC
    Identifying Residual Nodal Disease in Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2019 Aug 19. pii: 10.1245/s10434-019-07733.
    PubMed    


  154. LOVEJOY LA, Eaglehouse YL, Hueman MT, Mostoller BJ, et al
    Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital.
    Ann Surg Oncol. 2019 Aug 13. pii: 10.1245/s10434-019-07706.
    PubMed     Abstract available


  155. QIU PF, Zhao RR, Wang W, Sun X, et al
    Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management.
    Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07705.
    PubMed     Abstract available


  156. WALSH SM, Brennan SB, Zabor EC, Rosenberger LH, et al
    Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?
    Ann Surg Oncol. 2019 Aug 8. pii: 10.1245/s10434-019-07647.
    PubMed     Abstract available


  157. SACCHINI V
    Restaging Patients With Locoregional Relapse: Is There Any Benefit? : Commentary on "Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommenda
    Ann Surg Oncol. 2019 Aug 5. pii: 10.1245/s10434-019-07642.
    PubMed    


  158. ZHOU K, Li X
    ASO Author Reflections: Consideration of a Comprehensive and Progressive Upper Limb Exercise Program Following Surgery in Women with Breast Cancer.
    Ann Surg Oncol. 2019 Aug 5. pii: 10.1245/s10434-019-07681.
    PubMed    


  159. KANTOR O, Bao J, Jaskowiak N, Yao K, et al
    The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2019 Aug 2. pii: 10.1245/s10434-019-07636.
    PubMed     Abstract available


  160. MURPHY BL, Day CN, Hoskin TL, Habermann EB, et al
    Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties.
    Ann Surg Oncol. 2019 Aug 2. pii: 10.1245/s10434-019-07653.
    PubMed     Abstract available


    July 2019
  161. ZHANG F, Huang M, Zhou H, Chen K, et al
    A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07655.
    PubMed     Abstract available


  162. BARTH RJ JR, Krishnaswamy V, Paulsen KD, Rooney TB, et al
    A Randomized Prospective Trial of Supine MRI-Guided Versus Wire-Localized Lumpectomy for Breast Cancer.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07531.
    PubMed     Abstract available


  163. SAWAKI M, Kodaira T, Iwata H
    ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07658.
    PubMed    


  164. SAMIEI S, van Kaathoven BN, Boersma L, Granzier RWY, et al
    Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07643.
    PubMed     Abstract available


  165. KRUG D, Lederer B, Seither F, Nekljudova V, et al
    Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
    Ann Surg Oncol. 2019 Jul 26. pii: 10.1245/s10434-019-07635.
    PubMed     Abstract available


  166. RIVERA-BUENDIA F, Franco-Cendejas R, Roman-Lopez CG, Colin-Castro CA, et al
    Randomized Controlled Trial to Reduce Bacterial Colonization of Surgical Drains with the Use of Chlorhexidine-Coated Dressings After Breast Cancer Surgery.
    Ann Surg Oncol. 2019 Jul 25. pii: 10.1245/s10434-019-07631.
    PubMed     Abstract available


  167. DINOME ML, Orozco JIJ, Matsuba C, Manughian-Peter AO, et al
    Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07565.
    PubMed     Abstract available


  168. MASCIELLO MC, Bartholomew AJ, Haslinger M, Bozzuto LM, et al
    Physician Perspectives on Fertility Preservation Discussions with Premenopausal Breast Cancer Patients: Results from a Multihospital Health Care System.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07563.
    PubMed     Abstract available


  169. AL-HILLI Z, Grobmyer SR
    Management Strategies for Locally Recurrent Breast Cancer: Redo-Lumpectomy, Redo-Sentinel Node Biopsy, Redo-Radiation.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07545.
    PubMed     Abstract available


  170. OROZCO JIJ, Grumley JG, Matsuba C, Manughian-Peter AO, et al
    Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07567.
    PubMed     Abstract available


  171. CHANG J, Seng S, Yoo J, Equivel P, et al
    Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07595.
    PubMed     Abstract available


  172. JOHNSON HM, Mitchell KB
    Breastfeeding and Breast Cancer: Managing Lactation in Survivors and Women with a New Diagnosis.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07596.
    PubMed     Abstract available


  173. WONG SM, Chun YS, Sagara Y, Golshan M, et al
    National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07554.
    PubMed     Abstract available


  174. IMEOKPARIA FO, Hughes TM, Dossett LA, Jeruss JS, et al
    Axillary Pathologic Complete Response in Inflammatory Breast Cancer Patients: Implications for SLNB?
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07597.
    PubMed     Abstract available


  175. KANTOR O, Barrera E, Kopkash K, Pesce C, et al
    Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx((R)) for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07555.
    PubMed     Abstract available


  176. KANTOR O, Chang C, Bleicher RJ, Moran M, et al
    Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07559.
    PubMed     Abstract available


  177. SCHMOCKER S, Gotlib Conn L, Kennedy ED, Zhong T, et al
    Striving to Do No Harm and Yet Respect Patient Autonomy: Plastic Surgeons' Perspectives of the Consultation for Breast Reconstruction with Women Who Have Early-Stage Breast Cancer.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07541.
    PubMed     Abstract available


  178. CIAMBELLA CC, Taneja C, Dizon DS, Wiggins DL, et al
    Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07544.
    PubMed     Abstract available


  179. SROUR MK, Lee M, Walcott-Sapp S, Luu M, et al
    Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07543.
    PubMed     Abstract available


  180. SROUR MK, Tseng J, Luu M, Alban RF, et al
    Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07540.
    PubMed     Abstract available


  181. SUN S, van la Parra RFD, Rauch GM, Checka C, et al
    Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07533.
    PubMed     Abstract available


  182. MANAHAN ER, Kuerer HM, Sebastian M, Hughes KS, et al
    Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
    Ann Surg Oncol. 2019 Jul 24. pii: 10.1245/s10434-019-07549.
    PubMed     Abstract available


  183. ELFGEN C, Schmid SM, Tausch CJ, Montagna G, et al
    Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommendations?
    Ann Surg Oncol. 2019 Jul 22. pii: 10.1245/s10434-019-07629.
    PubMed     Abstract available


  184. KUPSTAS AR, Hoskin TL, Day CN, Habermann EB, et al
    Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.
    Ann Surg Oncol. 2019 Jul 22. pii: 10.1245/s10434-019-07566.
    PubMed     Abstract available


  185. GUTH U
    ASO Author Reflections: Routine Radiologic Staging of Distant Metastases Must Be Recommended as a Binding Guideline After Diagnosis of Local Breast Cancer Recurrence.
    Ann Surg Oncol. 2019 Jul 16. pii: 10.1245/s10434-019-07610.
    PubMed    


  186. ALVARADO MD, Mittendorf EA, Teshome M, Thompson AM, et al
    SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2019 Jul 11. pii: 10.1245/s10434-019-07577.
    PubMed     Abstract available


    June 2019
  187. DE LA CRUZ LM, Thiruchelvam PTR, Shivani J, Trina J, et al
    Saving the Male Breast: A Systematic Literature Review of Breast-Conservation Surgery for Male Breast Cancer.
    Ann Surg Oncol. 2019 Jun 27. pii: 10.1245/s10434-019-07588.
    PubMed     Abstract available


  188. YUAN Q, Wu G, Xiao SY, Hou J, et al
    Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.
    Ann Surg Oncol. 2019 Jun 25. pii: 10.1245/s10434-019-07569.
    PubMed     Abstract available


  189. WONG SM, Almana N, Choi J, Hu J, et al
    Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2019 Jun 21. pii: 10.1245/s10434-019-07517.
    PubMed     Abstract available


  190. LAWS A, Hughes ME, Hu J, Barry WT, et al
    Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2019 Jun 20. pii: 10.1245/s10434-019-07515.
    PubMed     Abstract available


  191. VAN STEENHOVEN JEC, Kuijer A, Schreuder K, Elias SG, et al
    The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07511.
    PubMed     Abstract available


  192. WHITWORTH P
    Response to: "Intact Excision of Breast Lesions Using BLES: Is There a Clinical Indication Yet?"
    Ann Surg Oncol. 2019;26:1950-1951.
    PubMed    


  193. GOOCH JC, Yoon E, Chun J, Kaplowitz E, et al
    The Relationship of Breast Density and Positive Lumpectomy Margins.
    Ann Surg Oncol. 2019;26:1729-1736.
    PubMed     Abstract available


  194. PARK KU, Kuerer HM, Rauch GM, Leung JWT, et al
    Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery.
    Ann Surg Oncol. 2019;26:1720-1728.
    PubMed     Abstract available


  195. PARK JW, Lee KT, Jeon BJ, Pyon JK, et al
    Effects of Antihypertensive Drugs on Outcomes of Breast Reconstruction.
    Ann Surg Oncol. 2019;26:1712-1719.
    PubMed     Abstract available


  196. KUEHNER G, Darbinian J, Habel L, Axelsson K, et al
    Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance.
    Ann Surg Oncol. 2019;26:1695-1703.
    PubMed     Abstract available


    May 2019
  197. ZHU S, Wu J, Huang O, He J, et al
    Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample.
    Ann Surg Oncol. 2019 May 29. pii: 10.1245/s10434-019-07480.
    PubMed     Abstract available


  198. MIYASHITA M, Niikura N, Kumamaru H, Miyata H, et al
    Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
    Ann Surg Oncol. 2019 May 17. pii: 10.1245/s10434-019-07453.
    PubMed     Abstract available


  199. FLANAGAN MR, Pilewskie ML
    ASO Author Reflections: Variation in the Use of Chemoprevention According to Breast Cancer Risk Factor.
    Ann Surg Oncol. 2019 May 17. pii: 10.1245/s10434-019-07460.
    PubMed    


  200. SAUDER CAM
    ASO Author Reflections: Surgical Treatment for Male Breast Cancer in the Modern Era.
    Ann Surg Oncol. 2019 May 9. pii: 10.1245/s10434-019-07359.
    PubMed    


  201. JUNG SY, Han JH, Park SJ, Lee EG, et al
    The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Pha
    Ann Surg Oncol. 2019 May 7. pii: 10.1245/s10434-019-07400.
    PubMed     Abstract available


  202. RETROUVEY H, Kerrebijn I, Metcalfe KA, O'Neill AC, et al
    Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction.
    Ann Surg Oncol. 2019 May 6. pii: 10.1245/s10434-019-07251.
    PubMed     Abstract available


  203. RIDNER SH, Dietrich MS, Cowher MS, Taback B, et al
    A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ann Surg Oncol. 2019 May 3. pii: 10.1245/s10434-019-07344.
    PubMed     Abstract available


  204. HENNIGS A, Riedel F, Feisst M, Kopke M, et al
    Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
    Ann Surg Oncol. 2019 May 2. pii: 10.1245/s10434-019-07388.
    PubMed     Abstract available


  205. HAVEL L, Landercasper J
    ASO Author Reflections: Rapid Uptake of the SSO ASTRO Margin Guideline and Decreased Reoperations After Lumpectomy: A Success Story.
    Ann Surg Oncol. 2019;26:1245-1246.
    PubMed    


  206. PAPASSOTIROPOULOS B, Guth U, Chiesa F, Rageth C, et al
    Prospective Evaluation of Residual Breast Tissue After Skin- or Nipple-Sparing Mastectomy: Results of the SKINI-Trial.
    Ann Surg Oncol. 2019;26:1254-1262.
    PubMed     Abstract available


  207. CHAGPAR AB
    Defining Why the Re-excision Rate Dropped.
    Ann Surg Oncol. 2019;26:1176-1177.
    PubMed    


  208. MILLER ME, Yao KA
    ASO Author Reflections: Breast Center Accreditation and Performance: Impact on Patient Care?
    Ann Surg Oncol. 2019;26:1212-1213.
    PubMed    


  209. MCKEVITT E, Kuusk U, Dingee C, Warburton R, et al
    Immediate Reconstruction Swing Room Scheduling Reduces Wait Times to Surgery and Increases Breast Reconstruction Rates.
    Ann Surg Oncol. 2019;26:1276-1283.
    PubMed     Abstract available


  210. MILLER ME, Bleicher RJ, Kaufman CS, Kurtzman SH, et al
    Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
    Ann Surg Oncol. 2019;26:1202-1211.
    PubMed     Abstract available


  211. YOON AY, Bozzuto L, Seto AJ, Fisher CS, et al
    A Systematic Review of Utility Score Assessments in the Breast Surgery Cost-Analysis Literature.
    Ann Surg Oncol. 2019;26:1190-1201.
    PubMed     Abstract available


  212. LU Y, Chen Y, Zhu L, Cartwright P, et al
    Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2019;26:1263-1275.
    PubMed     Abstract available


    April 2019
  213. BEAR HD, McGuire KP
    Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters.
    Ann Surg Oncol. 2019 Apr 24. pii: 10.1245/s10434-019-07401.
    PubMed    


  214. SAWAKI M, Miyamoto T, Fujisawa T, Itoh Y, et al
    Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
    Ann Surg Oncol. 2019 Apr 16. pii: 10.1245/s10434-019-07350.
    PubMed     Abstract available


  215. GWARK SC, Lee HS, Lee Y, Lee SB, et al
    Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
    Ann Surg Oncol. 2019 Apr 11. pii: 10.1245/s10434-019-07332.
    PubMed     Abstract available


  216. ZHOU K, Wang W, An J, Li M, et al
    Effects of Progressive Upper Limb Exercises and Muscle Relaxation Training on Upper Limb Function and Health-Related Quality of Life Following Surgery in Women with Breast Cancer: A Clinical Randomized Controlled Trial.
    Ann Surg Oncol. 2019 Apr 10. pii: 10.1245/s10434-019-07305.
    PubMed     Abstract available


  217. MCDONALD KA, Kawaguchi T, Qi Q, Peng X, et al
    Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.
    Ann Surg Oncol. 2019 Apr 8. pii: 10.1245/s10434-019-07338.
    PubMed     Abstract available


  218. WHITWORTH P, Schonholz S, Phillips R, Robertson Y, et al
    Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry.
    Ann Surg Oncol. 2019;26:954-960.
    PubMed     Abstract available


  219. DOWNS-CANNER S, Zabor EC, Wind T, Cobovic A, et al
    Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose?
    Ann Surg Oncol. 2019;26:969-975.
    PubMed     Abstract available


  220. YAO K
    Intact Excision of Breast Lesions Using BLES: Is There a Clinical Indication Yet?
    Ann Surg Oncol. 2019;26:933-935.
    PubMed    


  221. ZHANG L, Jin K, Wang X, Yang Z, et al
    The Impact of Radiotherapy on Reoperation Rates in Patients Undergoing Mastectomy and Breast Reconstruction.
    Ann Surg Oncol. 2019;26:961-968.
    PubMed     Abstract available


    March 2019
  222. KANDAGATLA P, Shah NM, Jeruss JS
    ASO Author Reflections: Challenges in the Management of Young Women with Breast Cancer-Fertility Preservation and Pregnancy.
    Ann Surg Oncol. 2019 Mar 11. pii: 10.1245/s10434-019-07285.
    PubMed    


  223. VAN BOMMEL A, Spronk P, Mureau M, Siesling S, et al
    Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07265.
    PubMed     Abstract available


  224. WARNBERG F, Stigberg E, Obondo C, Olofsson H, et al
    Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07239.
    PubMed     Abstract available


  225. WANG MM, Joseph KA
    ASO Author Reflections: Improving the Rate of Breast Reconstruction in Underserved Populations.
    Ann Surg Oncol. 2019;26:827-828.
    PubMed    


  226. HOSKIN TL, Boughey JC, Day CN, Habermann EB, et al
    Lessons Learned Regarding Missing Clinical Stage in the National Cancer Database.
    Ann Surg Oncol. 2019;26:739-745.
    PubMed     Abstract available


    February 2019
  227. FLANAGAN MR, Zabor EC, Stempel M, Mangino DA, et al
    Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor.
    Ann Surg Oncol. 2019 Feb 27. pii: 10.1245/s10434-019-07236.
    PubMed     Abstract available


  228. MITTENDORF EA, King TA
    Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come.
    Ann Surg Oncol. 2019 Feb 24. pii: 10.1245/s10434-019-07240.
    PubMed    


  229. WOOD ME, Cuke M, Bedrosian I
    Prevention Therapy for Breast Cancer: How Can We Do Better?
    Ann Surg Oncol. 2019 Feb 23. pii: 10.1245/s10434-019-07243.
    PubMed    


  230. HAVEL L, Naik H, Ramirez L, Morrow M, et al
    Impact of the SSO-ASTRO Margin Guideline on Rates of Re-excision After Lumpectomy for Breast Cancer: A Meta-analysis.
    Ann Surg Oncol. 2019 Feb 21. pii: 10.1245/s10434-019-07247.
    PubMed     Abstract available


  231. PEASE AM, James TA
    ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Ann Surg Oncol. 2019 Feb 19. pii: 10.1245/s10434-019-07244.
    PubMed    


  232. BATENI SB, Davidson AJ, Arora M, Daly ME, et al
    Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.
    Ann Surg Oncol. 2019 Feb 13. pii: 10.1245/s10434-019-07159.
    PubMed     Abstract available


  233. SELLA T, Partridge AH
    Reproductive Health Issues for Young Women with Breast Cancer: Emerging Strategies for Difficult Situations.
    Ann Surg Oncol. 2019 Feb 1. pii: 10.1245/s10434-019-07205.
    PubMed    


    January 2019
  234. WANG M, Wu K, Chen H
    ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the Updated AJCC 8th Edition for T1-2N1M0 ER-Positive HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07198.
    PubMed    


  235. SHAH NM, Scott DM, Kandagatla P, Moravek MB, et al
    Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.
    Ann Surg Oncol. 2019 Jan 24. pii: 10.1245/s10434-019-07156.
    PubMed     Abstract available


  236. VAN LOEVEZIJN AA, van der Ploeg IMC
    ASO Author Reflections: A Reappraisal of Internal Mammary Chain Sentinel Node Biopsy in Breast Cancer Patients: Recommendations for Clinical Practice.
    Ann Surg Oncol. 2019 Jan 23. pii: 10.1245/s10434-019-07194.
    PubMed    


  237. SCHWARTZ TL, Margenthaler JA
    Value-Based Analysis for Breast Cancer Treatment: We Don't Know What We Don't Know.
    Ann Surg Oncol. 2019 Jan 23. pii: 10.1245/s10434-019-07170.
    PubMed    


    December 2018
  238. ADESOYE T, Schumacher J, Greenberg CC
    ASO Author Reflections: Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
    Ann Surg Oncol. 2018 Dec 18. pii: 10.1245/s10434-018-7070.
    PubMed    


  239. TEVIS SE, Bassett R, Bedrosian I, Barcenas CH, et al
    OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.
    Ann Surg Oncol. 2018 Dec 17. pii: 10.1245/s10434-018-7059.
    PubMed     Abstract available


  240. ROSENKRANZ KM, Ballman K, McCall L, Kubicky CD, et al
    Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report".
    Ann Surg Oncol. 2018 Dec 12. pii: 10.1245/s10434-018-6984.
    PubMed    


  241. CAO L, Xu C, Kirova YM, Cai G, et al
    The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0-1.
    Ann Surg Oncol. 2018 Dec 5. pii: 10.1245/s10434-018-07095.
    PubMed     Abstract available


    November 2018
  242. VAN DER NOORDAA MEM, Vrancken Peeters MTFD
    ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients.
    Ann Surg Oncol. 2018 Nov 26. pii: 10.1245/s10434-018-6975.
    PubMed    


  243. SHARMA R
    ASO Author Reflections: Eighty is the New Sixty-Breast Cancer Treatment Strategies in the Octogenarian Patient Population.
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7071.
    PubMed    


  244. VAN LOEVEZIJN AA, Bartels SAL, van Duijnhoven FH, Heemsbergen WD, et al
    Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal.
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7058.
    PubMed     Abstract available


  245. WANG M, Wu K, Zhang P, Zhang M, et al
    The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7068.
    PubMed     Abstract available


  246. WINTERS ZE, Benson JR
    Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-6982.
    PubMed    


  247. FAYANJU OM
    ASO Author Reflections: Metaplastic Breast Cancer-The Case for Doing Less and More.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7009.
    PubMed    


  248. ELDER K, Nickson C, Mann GB
    ASO Author Reflections: Impact of Breast Cancer Screening Beyond Mortality Reductions.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7001.
    PubMed    


  249. ROOS MM, van Steenhoven JEC, Aalders KC, Schreuder K, et al
    Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
    Ann Surg Oncol. 2018 Nov 1. pii: 10.1245/s10434-018-6940.
    PubMed     Abstract available


    October 2018
  250. BAZAN JG, White JR
    ASO Author Reflections: Shifting the Focus of pT1-2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?
    Ann Surg Oncol. 2018 Oct 30. pii: 10.1245/s10434-018-6986.
    PubMed    


  251. ALTMAN AM, Marmor S
    ASO Author Reflections: 21-Gene Recurrence Scores in Male Breast Cancer.
    Ann Surg Oncol. 2018 Oct 29. pii: 10.1245/s10434-018-6951.
    PubMed    


  252. NAKHLIS F, Harrison BT, Giess CS, Lester SC, et al
    Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6937.
    PubMed     Abstract available


  253. SORAN A
    ASO Author Reflections: Is Intensifying Loco-Regional Treatment in the Early Course of De Novo Stage IV Breast Cancer Reasonable?
    Ann Surg Oncol. 2018 Oct 24. pii: 10.1245/s10434-018-6924.
    PubMed    


  254. LANDERCASPER J
    ASO Author Reflections: Nudging Surgeon Stewards of Breast Cancer Quality Measurement Programs Toward More Patient-Centeredness.
    Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6923.
    PubMed    


  255. HILAL T, Patel BK
    ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2018 Oct 15. pii: 10.1245/s10434-018-6899.
    PubMed    


  256. WEISS A
    ASO Author Reflections: Reconstruction in the Metastatic Breast Cancer Patient-Shifting Focus to Quality of Life.
    Ann Surg Oncol. 2018 Oct 15. pii: 10.1245/s10434-018-6911.
    PubMed    


  257. KAWAGUCHI T, Yan L, Qi Q, Peng X, et al
    Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6859.
    PubMed     Abstract available


  258. LANG JE, Brownson KE
    ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6888.
    PubMed    


  259. LAIRD J, Braunstein LZ
    ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.
    Ann Surg Oncol. 2018 Oct 10. pii: 10.1245/s10434-018-6889.
    PubMed    


  260. JAMES TA
    ASO Author Reflections: Addressing Surgery-Specific Risk Factors Influencing Time to Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2018 Oct 9. pii: 10.1245/s10434-018-6852.
    PubMed    


  261. CRONIN PA, Romanoff A, Zabor EC, Stempel M, et al
    Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6767.
    PubMed     Abstract available


  262. SCHWARTZBERG B, Lewin J, Abdelatif O, Bernard J, et al
    Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6861.
    PubMed     Abstract available


  263. RUBIO IT
    ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6849.
    PubMed    


  264. MERRILL AY, Ochoa D, Klimberg VS, Hill EL, et al
    Cutting Healthcare Costs with Hematoma-Directed Ultrasound-Guided Breast Lumpectomy.
    Ann Surg Oncol. 2018;25:3076-3081.
    PubMed     Abstract available


  265. TADROS AB, Wen HY, Morrow M
    Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.
    Ann Surg Oncol. 2018;25:3158-3164.
    PubMed     Abstract available


  266. MAMOUNAS EP
    Omitting Surgery in Complete Responders After Neoadjuvant Chemotherapy: The Quest Continues.
    Ann Surg Oncol. 2018;25:3119-3122.
    PubMed    


    September 2018
  267. HARNESS JK, Shah C
    ASO Author Reflections: Meta-Analysis of Local Recurrence of Invasive Breast Cancer After Electron Intraoperative Radiotherapy.
    Ann Surg Oncol. 2018 Sep 27. pii: 10.1245/s10434-018-6791.
    PubMed    


  268. HAQUE W, Teh BS
    Current Practice and Future Directions for Metaplastic Breast Cancer.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6783.
    PubMed    


  269. RAUCH GM
    ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6780.
    PubMed    


  270. PARTAIN NS, Hunt KK
    Imaging Surveillance After Definitive Treatment for Breast Cancer.
    Ann Surg Oncol. 2018 Sep 20. pii: 10.1245/s10434-018-6745.
    PubMed    


  271. LANDERCASPER J
    Correction to: Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle.
    Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6748.
    PubMed     Abstract available


  272. LAGENDIJK M, van Egdom LSE, van Veen FEE, Vos EL, et al
    Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery.
    Ann Surg Oncol. 2018 Sep 3. pii: 10.1245/s10434-018-6729.
    PubMed     Abstract available


    August 2018
  273. THEOBALD KA, Susswein LR, Marshall ML, Roberts ME, et al
    Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
    Ann Surg Oncol. 2018 Aug 30. pii: 10.1245/s10434-018-6581.
    PubMed     Abstract available


  274. WEISS A, Chu CK, Lin H, Shen Y, et al
    Reconstruction in the Metastatic Breast Cancer Patient: Results from the National Cancer Database.
    Ann Surg Oncol. 2018 Aug 14. pii: 10.1245/s10434-018-6693.
    PubMed     Abstract available


  275. MAXWELL J
    Reconstruction in the Setting of Metastatic Breast Cancer: A Challenging Clinical Question.
    Ann Surg Oncol. 2018 Aug 7. pii: 10.1245/s10434-018-6701.
    PubMed    


  276. WU S, Wang Y, Zhang N, Li J, et al
    Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6548.
    PubMed     Abstract available


    July 2018
  277. CAUDLE AS
    Intraoperative Pathologic Evaluation with Targeted Axillary Dissection : Editorial for "Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy Among Breast Cancer Patients with Initial Axillary Metastasis"
    Ann Surg Oncol. 2018 Jul 27. pii: 10.1245/s10434-018-6666.
    PubMed    


  278. KUERER HM
    Increasing Breast Cancer Systemic Therapy Use Before Surgery in the United States: Scaling Down and the Promise of Selective Elimination of Surgery.
    Ann Surg Oncol. 2018 Jul 26. pii: 10.1245/s10434-018-6643.
    PubMed    


  279. LORENZEN AW, Kiriazov B, De Andrade JP, Lizarraga IM, et al
    Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community.
    Ann Surg Oncol. 2018 Jul 20. pii: 10.1245/s10434-018-6574.
    PubMed     Abstract available


  280. BELLO DM, Russell C, McCullough D, Tierno M, et al
    Correction to: Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
    Ann Surg Oncol. 2018 Jul 19. pii: 10.1245/s10434-018-6667.
    PubMed     Abstract available


  281. BARBIE TU, Golshan M
    De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease?
    Ann Surg Oncol. 2018 Jul 17. pii: 10.1245/s10434-018-6664.
    PubMed    


  282. DE LA CRUZ LM, Czerniecki BJ
    Immunotherapy for Breast Cancer is Finally at the Doorstep: Immunotherapy in Breast Cancer.
    Ann Surg Oncol. 2018 Jul 16. pii: 10.1245/s10434-018-6620.
    PubMed     Abstract available


  283. JABO B, Lin AC, Aljehani MA, Ji L, et al
    Impact of Breast Reconstruction on Time to Definitive Surgical Treatment, Adjuvant Therapy, and Breast Cancer Outcomes.
    Ann Surg Oncol. 2018 Jul 16. pii: 10.1245/s10434-018-6663.
    PubMed     Abstract available


  284. SHILAD S, Cakmakoglu C, Schwarz G, Valente S, et al
    Triple Mapping to Optimize Axillary Management in Breast Cancer Patients After Neoadjuvant Therapy.
    Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6645.
    PubMed    


  285. AHN S, Wooster M, Valente C, Moshier E, et al
    Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6646.
    PubMed     Abstract available


  286. WU SP, Tam M, Shaikh F, Lee A, et al
    Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6632.
    PubMed     Abstract available


  287. ROSENKRANZ KM, Ballman K, McCall L, Kubicky C, et al
    The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6583.
    PubMed     Abstract available


  288. SCHWARTZBERG B, Lewin J, Abdelatif O, Bernard J, et al
    Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6623.
    PubMed     Abstract available


  289. KILGORE LJ, Korentager SS, Hangge AN, Amin AL, et al
    Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6601.
    PubMed     Abstract available


  290. DE LA CRUZ LM, Harhay MO, Zhang P, Ugras S, et al
    Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Jul 6. pii: 10.1245/s10434-018-6608.
    PubMed     Abstract available


  291. SHIMAZU K, Sato N, Ogiya A, Sota Y, et al
    Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6633.
    PubMed     Abstract available


  292. NGUYEN TT, Hoskin TL, Day CN, Degnim AC, et al
    Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6637.
    PubMed     Abstract available


  293. PARK TS, Thomas SM, Rosenberger LH, Fayanju OM, et al
    The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6587.
    PubMed     Abstract available


  294. LANDERCASPER J
    Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle at the Massachusetts General Hospital.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6609.
    PubMed    


  295. XU Y, Bouchard-Fortier A, Olivotto IA, Cheung WY, et al
    'Driving' Rates Down: A Population-Based Study of Opening New Radiation Therapy Centers on the Use of Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6619.
    PubMed     Abstract available


  296. GARCIA D, Spruill LS, Irshad A, Wood J, et al
    The Value of a Second Opinion for Breast Cancer Patients Referred to a National Cancer Institute (NCI)-Designated Cancer Center with a Multidisciplinary Breast Tumor Board.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6599.
    PubMed     Abstract available


  297. TEVIS SE, James TA, Kuerer HM, Pusic AL, et al
    Patient-Reported Outcomes for Breast Cancer.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6616.
    PubMed     Abstract available


  298. OLLILA DW, Hwang ES, Brenin DR, Kuerer HM, et al
    The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations.
    Ann Surg Oncol. 2018 Jul 2. pii: 10.1245/s10434-018-6618.
    PubMed     Abstract available


  299. BLEICHER RJ
    Timing and Delays in Breast Cancer Evaluation and Treatment.
    Ann Surg Oncol. 2018 Jul 2. pii: 10.1245/s10434-018-6615.
    PubMed     Abstract available


  300. TAMIRISA N, Thomas SM, Fayanju OM, Greenup RA, et al
    Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival.
    Ann Surg Oncol. 2018 Jul 2. pii: 10.1245/s10434-018-6595.
    PubMed     Abstract available


  301. BELLO DM, Russell C, McCullough D, Tierno M, et al
    Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
    Ann Surg Oncol. 2018 Jul 2. pii: 10.1245/s10434-018-6598.
    PubMed     Abstract available


  302. YAO K, Boughey JC
    'Nudging' Surgeons and Patients to De-Escalation of Surgery for Breast Cancer.
    Ann Surg Oncol. 2018 Jul 2. pii: 10.1245/s10434-018-6588.
    PubMed    


    June 2018
  303. MURPHY BL, Ray-Zack MD, Reddy PN, Choudhry AJ, et al
    Breast Cancer Litigation in the 21st Century.
    Ann Surg Oncol. 2018 Jun 28. pii: 10.1245/s10434-018-6579.
    PubMed     Abstract available


  304. CHAGPAR AB, Wilke LG
    Should Reexcision Rates in Breast Cancer Care be a Quality Measure?
    Ann Surg Oncol. 2018 Jun 26. pii: 10.1245/s10434-018-6576.
    PubMed    


  305. BAZAN JG, Majithia L, Quick AM, Wobb JL, et al
    Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates.
    Ann Surg Oncol. 2018 Jun 18. pii: 10.1245/s10434-018-6565.
    PubMed     Abstract available


  306. ALTMAN AM, Kizy S, Yuan J, Denbo JW, et al
    Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States.
    Ann Surg Oncol. 2018 Jun 15. pii: 10.1245/s10434-018-6566.
    PubMed     Abstract available


  307. SHAH C, Al-Hilli Z, Schwarz G
    Oncoplastic Surgery in Breast Cancer: Don't Forget the Boost!
    Ann Surg Oncol. 2018 Jun 15. pii: 10.1245/s10434-018-6571.
    PubMed    


  308. WEBER WP, Tausch C, Hayoz S, Fehr MK, et al
    Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial.
    Ann Surg Oncol. 2018 Jun 8. pii: 10.1245/s10434-018-6556.
    PubMed     Abstract available


  309. GROSSMITH S, Nguyen A, Hu J, Plichta JK, et al
    Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.
    Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6525.
    PubMed     Abstract available


  310. LANG JE, Ring A, Porras T, Kaur P, et al
    RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
    Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6540.
    PubMed     Abstract available


  311. WELLINGTON J, Sanders T, Mylander C, Alden A, et al
    Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
    Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6545.
    PubMed     Abstract available


    May 2018
  312. ONG CT, Campbell BM, Thomas SM, Greenup RA, et al
    Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
    Ann Surg Oncol. 2018 May 31. pii: 10.1245/s10434-018-6533.
    PubMed     Abstract available


  313. MOOSSDORFF M, Nakhlis F, Hu J, Barry WT, et al
    The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Ann Surg Oncol. 2018 May 31. pii: 10.1245/s10434-018-6519.
    PubMed     Abstract available


  314. MURPHY BL, Day CN, Hoskin TL, Habermann EB, et al
    Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.
    Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6531.
    PubMed     Abstract available


  315. SORAN A, Ozmen V, Ozbas S, Karanlik H, et al
    Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
    Ann Surg Oncol. 2018 May 17. pii: 10.1245/s10434-018-6494.
    PubMed     Abstract available


  316. SCHUMACHER JR, Neuman HB, Chang GJ, Kozower BD, et al
    A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
    Ann Surg Oncol. 2018 May 17. pii: 10.1245/s10434-018-6496.
    PubMed     Abstract available


  317. ELDER K, Nickson C, Pattanasri M, Cooke S, et al
    Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
    Ann Surg Oncol. 2018 May 1. pii: 10.1245/s10434-018-6469.
    PubMed     Abstract available


    April 2018
  318. PARK KU, Chen Y, Chitale D, Choi S, et al
    Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Apr 20. pii: 10.1245/s10434-018-6440.
    PubMed     Abstract available


  319. DUNHAM AL, Ramirez LD, Vang CA, Linebarger JH, et al
    Profiling Surgeon Performance for Breast Cancer Lumpectomy by Composite Measurement of Reoperations, Cosmetic Outcomes, and Patient Preferences.
    Ann Surg Oncol. 2018 Apr 18. pii: 10.1245/s10434-018-6479.
    PubMed     Abstract available


  320. GIULIANO AE, Edge SB, Hortobagyi GN
    Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.
    Ann Surg Oncol. 2018 Apr 18. pii: 10.1245/s10434-018-6486.
    PubMed    


  321. RAUCH GM, Kuerer HM, Adrada B, Santiago L, et al
    Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints.
    Ann Surg Oncol. 2018 Apr 17. pii: 10.1245/s10434-018-6481.
    PubMed     Abstract available


  322. EXMAN P, Burstein HJ
    How Old is Too Old? Breast Cancer Treatment in Octogenarians.
    Ann Surg Oncol. 2018 Apr 9. pii: 10.1245/s10434-018-6457.
    PubMed    


    March 2018
  323. DE MELO GAGLIATO D, Chavez-MacGregor M
    Delays in Adjuvant Chemotherapy Among Breast Cancer Patients: An Unintended Consequence of Breast Surgery?
    Ann Surg Oncol. 2018 Mar 29. pii: 10.1245/s10434-018-6415.
    PubMed    


  324. MUHSEN S, Moo TA, Patil S, Stempel M, et al
    Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.
    Ann Surg Oncol. 2018 Mar 21. pii: 10.1245/s10434-018-6422.
    PubMed     Abstract available


  325. TURASHVILI G, Gonzalez-Loperena M, Brogi E, Dickler M, et al
    The 21-Gene Recurrence Score in Male Breast Cancer.
    Ann Surg Oncol. 2018 Mar 8. pii: 10.1245/s10434-018-6411.
    PubMed     Abstract available


  326. PATEL BK, Hilal T, Covington M, Zhang N, et al
    Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2018 Mar 7. pii: 10.1245/s10434-018-6413.
    PubMed     Abstract available


  327. DE LA CRUZ LM, Shulman LN
    'Under' Surveillance: Impact of Race and Socioeconomic Status on Post-Treatment Breast Cancer Imaging.
    Ann Surg Oncol. 2018 Mar 7. pii: 10.1245/s10434-018-6418.
    PubMed    


  328. VAN DER NOORDAA MEM, van Duijnhoven FH, Straver ME, Groen EJ, et al
    Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
    Ann Surg Oncol. 2018 Mar 6. pii: 10.1245/s10434-018-6404.
    PubMed     Abstract available


  329. OCHOA O, Azouz V, Santillan A, Pisano S, et al
    Internal Mammary Lymph Node Biopsy During Free-Flap Breast Reconstruction: Optimizing Adjuvant Breast Cancer Treatment Through Comprehensive Staging.
    Ann Surg Oncol. 2018 Mar 1. pii: 10.1245/s10434-018-6352.
    PubMed     Abstract available


    February 2018
  330. ADESOYE T, Schumacher JR, Neuman HB, Edge S, et al
    Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
    Ann Surg Oncol. 2018 Feb 15. pii: 10.1245/s10434-018-6359.
    PubMed     Abstract available


  331. MAMTANI A, Gonzalez JJ, Neo DT, Friedman RS, et al
    Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer.
    Ann Surg Oncol. 2018 Feb 9. pii: 10.1245/s10434-018-6350.
    PubMed     Abstract available


    January 2018
  332. RIBA LA, Gruner RA, Fleishman A, James TA, et al
    Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2018 Jan 30. pii: 10.1245/s10434-018-6351.
    PubMed     Abstract available


  333. KANTOR O, Sipsy LM, Yao K, James TA, et al
    A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2018 Jan 24. pii: 10.1245/s10434-018-6345.
    PubMed     Abstract available


  334. JANG N, Kwon HJ, Park MH, Kang SH, et al
    Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6332.
    PubMed     Abstract available


  335. HAQUE W, Verma V, Naik N, Butler EB, et al
    Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy.
    Ann Surg Oncol. 2018 Jan 10. pii: 10.1245/s10434-017-6316.
    PubMed     Abstract available


    December 2017
  336. SISO C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, et al
    Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
    Ann Surg Oncol. 2017 Dec 1. pii: 10.1245/s10434-017-6270.
    PubMed     Abstract available


    November 2017
  337. FAYANJU OM, Park KU, Lucci A
    Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6254.
    PubMed     Abstract available


  338. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Correction to: Reply to ''Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions".
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6259.
    PubMed     Abstract available


  339. FITZAL F, Helfgott R, Moinfar F, Gnant M, et al
    Sized Influences Nodal Status in Women Aged #70 with Endocrine Responsive Breast Cancer.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6156.
    PubMed    


  340. LANG JE, Tereffe W, Babiera G
    Primary Locoregional Treatment in Metastatic Breast Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 16. doi: 10.1245/s10434-017-6185.
    PubMed    


  341. MCINERNEY NM, O'Neill AC, Zhong T, Hofer SOP, et al
    Response to "Complications in DIEP Flap Breast Reconstruction after Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral and Bilateral Reconstructions".
    Ann Surg Oncol. 2017 Nov 16. doi: 10.1245/s10434-017-6172.
    PubMed    


  342. KIM WH, Kim HJ, Jung JH, Park HY, et al
    Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
    Ann Surg Oncol. 2017 Nov 13. doi: 10.1245/s10434-017-6250.
    PubMed     Abstract available


  343. KANTOR O, Ajmani G, Wang CH, Datta A, et al
    The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2017 Nov 10. doi: 10.1245/s10434-017-6217.
    PubMed     Abstract available


  344. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Reply to "Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions".
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6173.
    PubMed    


  345. HARNESS JK, Davies K, Via C, Brooks E, et al
    Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6130.
    PubMed     Abstract available


  346. COOPEY SB, Specht MC
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-Excision Rates in Breast Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6189.
    PubMed    


  347. GRANT WB
    Vitamin D Levels Affect Breast Cancer Survival Rates.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6159.
    PubMed    


  348. SUGIE T, Toi M
    Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 1. doi: 10.1245/s10434-017-6187.
    PubMed    


    October 2017
  349. KHOUBNASABJAFARI M, Ansarin K, Jouyban A
    Comments on "An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer".
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6182.
    PubMed    


  350. BOUGHEY JC, Hoskin TL, Welsh JL, Day CN, et al
    Using Size and Grade to Identify Women Aged >/= 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity : Letter to Editor Reply to "Sized influences nodal status in women aged >/= 70 with endocrine responsive breast can
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6158.
    PubMed    


  351. KILIC N
    Reply to An Investigation Into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products for Patients with Breast Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6183.
    PubMed    


  352. PITSINIS V, Wishart GC
    Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6186.
    PubMed    


  353. CRAGUN D, Vadaparampil S, Scherr C, Pal T, et al
    Comment on "Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey".
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6190.
    PubMed    


  354. WRAY CJ
    Vitamin D Levels Affect Breast Cancer Survival Rates: A Reply.
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6160.
    PubMed    


  355. BRICOU A, Sakr R, Barranger E
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6188.
    PubMed    


  356. TOPPS AR, Barr SP, Pikoulas P, Pritchard SA, et al
    Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6090.
    PubMed     Abstract available


  357. KESKEY RC, LaJoie AS, Sutton BS, Kim IK, et al
    Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6094.
    PubMed     Abstract available


  358. VIGNES S, Brorson H
    Comment on "Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy".
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6124.
    PubMed    


    September 2017
  359. GENTILE LF, Plitas G, Zabor EC, Stempel M, et al
    Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2017 Sep 15. doi: 10.1245/s10434-017-6085.
    PubMed     Abstract available


  360. ZHANG Y, Seely J, Cordeiro E, Hefler J, et al
    Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.
    Ann Surg Oncol. 2017 Sep 14. doi: 10.1245/s10434-017-6084.
    PubMed     Abstract available


  361. MCLAUGHLIN SA, Cornell LF, Mussallem DM
    Sexual Function and Breast-Specific Sensuality Remain Important After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 Sep 13. doi: 10.1245/s10434-017-6086.
    PubMed    


  362. DONOVAN CA, Giuliano AE
    Evolution of the Staging System in Breast Cancer.
    Ann Surg Oncol. 2017 Sep 8. doi: 10.1245/s10434-017-6035.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: